Загрузка...
A view on dendritic cell immunotherapy in ovarian cancer: how far have we come?
Ovarian cancer is the second most important pelvic gynaecologic malignancy and nowadays still kills 80% of patients. New treatment options are mandatory. Although it has been shown that ovarian cancer is an immunogenic tumor, the possibility of developing immunotherapy has been neglected for a long...
Сохранить в:
| Опубликовано в: : | Facts Views Vis Obgyn |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Universa Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4402447/ https://ncbi.nlm.nih.gov/pubmed/25897374 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|